|
HELQ expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62925228863742E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.80941936381396E-12 |
| Normal-vs-Stage2 |
2.48099985000749E-10 |
| Normal-vs-Stage3 |
1.55100376986184E-11 |
| Normal-vs-Stage4 |
2.21529461441605E-11 |
| Stage1-vs-Stage2 |
4.445600E-02 |
| Stage1-vs-Stage3 |
4.836800E-01 |
| Stage1-vs-Stage4 |
1.105040E-01 |
| Stage2-vs-Stage3 |
1.720040E-01 |
| Stage2-vs-Stage4 |
6.856000E-01 |
| Stage3-vs-Stage4 |
3.183200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.02060590481778E-14 |
| Normal-vs-AfricanAmerican |
1.60743999999546E-05 |
| Normal-vs-Asian |
1.0653000004357E-07 |
| Caucasian-vs-AfricanAmerican |
6.258400E-01 |
| Caucasian-vs-Asian |
3.440600E-01 |
| AfricanAmerican-vs-Asian |
8.328400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.33066907387547E-16 |
| Normal-vs-Female |
3.15836246045365E-12 |
| Male-vs-Female |
1.028350E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.07060027509931E-10 |
| Normal-vs-Age(41-60Yrs) |
2.78721490332146E-12 |
| Normal-vs-Age(61-80Yrs) |
1.89470661382529E-12 |
| Normal-vs-Age(81-100Yrs) |
1.65340999999097E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.441000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.353900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.189040E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.623000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.234200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.957800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.529800E-01 |
| Classical-VS-Follicular |
1.096500E-03 |
| Classical-VS-Other |
6.981800E-01 |
| Classical-VS-Normal |
4.10826928032293E-12 |
| Tall-VS-Follicular |
8.402400E-02 |
| Tall-VS-Other |
9.953400E-01 |
| Tall-VS-Normal |
1.40150000049744E-07 |
| Follicular-VS-Other |
4.695000E-01 |
| Follicular-VS-Normal |
3.24662519091135E-12 |
| Other-VS-Normal |
4.763000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.8288482667449E-13 |
| Normal-vs-N1 |
5.32340005410248E-09 |
| N0-vs-N1 |
5.615400E-01 |
|
|
